INSIGHTS ON DRUG DEVELOPMENT

• What Is DMPK, And Why Does It Matter In Drug Development?

  By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.

• The Role Of CRISPR Cas9 Plasmids In Gene-Editing

  Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.

• Developing High Concentration Biopharmaceuticals: Formulation Considerations

  This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.

• Rapid, Automated, At-Line Adenovirus Quantitation

  Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.

• Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development

  7/9/2025

  Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

• Solid State Hydrogen Deuterium Exchange To Study Antibody Drug Conjugate Stability

  10/16/2024

  Discover how this solid-state HDX-MS is being used to revolutionize the prediction of stability for IgG-based Antibody Drug Conjugates and enhance ADC development processes.

• A New Framework For Identifying Nitrosamine Risks And Derisking Products

  6/18/2024

  Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

• A Comparative Efficiency Analysis Of Commercial Transfection Reagents In HEK 293 Cells

  3/27/2025

  This study presents a detailed comparative analysis of the efficiency, viability, and cytotoxic effects of four widely used transfection reagents on Human Embryonic Kidney 293 (HEK293) cells.

• Modular Facilities With Smaller Footprint Through Dynamic Perfusion

  6/30/2025

  Discover how a top CDMO leveraged dynamic perfusion technology to boost biomanufacturing throughput, cut capital costs, and enable flexible, multi-modality production.